4.3 Editorial Material

Neurofilament light and heavy subunits compared as therapeutic biomarkers in multiple sclerosis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Clinical Neurology

Axonal Damage in Relapsing Multiple Sclerosis is Markedly Reduced by Natalizumab

Martin Gunnarsson et al.

ANNALS OF NEUROLOGY (2011)

Article Clinical Neurology

Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis

C. E. Teunissen et al.

NEUROLOGY (2009)

Article Clinical Neurology

Neurofilament phosphoforms: Surrogate markers for axonal injury, degeneration and loss

A Petzold

JOURNAL OF THE NEUROLOGICAL SCIENCES (2005)

Review Biotechnology & Applied Microbiology

Blocking adhesion molecules as therapy for multiple sclerosis: Natalizumab

L Steinman

NATURE REVIEWS DRUG DISCOVERY (2005)

Article Clinical Neurology

Neurofilament and glial fibrillary acidic protein in multiple sclerosis

N Norgren et al.

NEUROLOGY (2004)

Article Biochemical Research Methods

Monoclonal antibodies selective for low molecular weight neurofilaments

N Norgren et al.

HYBRIDOMA AND HYBRIDOMICS (2002)